Business · 29/05/2019Updated: 10/17/2026 · 1 min read
FDA Announces Collection of Information for Review by OMB
Summary
The Food and Drug Administration has submitted a proposed collection of information to the Office of Management and Budget for review and clearance, as required by the Paperwork Reduction Act of 1995, to report adverse events related to FDA-regulated products.
Original source language: Federal Register — Food and Drug AdministrationOpen original release →